Multiple predicted hub targets in p53 and FoxO signaling pathways

The term "Multiple predicted hub targets in p53 and FoxO signaling pathways" refers to a collection of central proteins identified through bioinformatic network analysis that play critical roles in cellular stress responses and homeostasis. These pathways, p53 and FoxO, are fundamental to maintaining genomic stability and regulating metabolism, respectively (PMID: 10751930, PMID: 21358639). Hub targets are defined as nodes with high connectivity in protein-protein interaction networks, often including proteins like Tumor protein p53 (TP53), MDM2, and AKT1 (PMID: 32812585). Because this term describes a functional group or a set of results from a bioinformatic study rather than a single molecular entity, it does not constitute a specific canonical therapeutic target. In a clinical context, drugs are developed to target specific components within these pathways, such as MDM2 inhibitors or AKT inhibitors, rather than the entire set of hub genes simultaneously. Dysregulation of these hub nodes is a hallmark of various cancers, where p53 is often mutated and FoxO factors are inactivated by overactive growth signaling. Consequently, while these hub targets are of high interest for drug discovery, they must be addressed individually to ensure therapeutic specificity and safety.

Other names

Hub genes of p53 signalingHub genes of FoxO signalingp53/FoxO pathway hub proteins

Varies by specific hub target; includes MDM2 inhibition to stabilize p53, AKT inhibition to prevent FoxO phosphorylation/inactivation, and SIRT1 modulation.